ISTA Pharmaceuticals, Inc. , today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the…
Carl Zeiss Meditec Introduces New Innovations: ‘Creating What’s To Come’ At AAO 2010
AAO Booth #1408 – Carl Zeiss Meditec today unveiled its newest product innovations at the 2010 American Academy of Ophthalmology annual meeting in Chicago. Powered by the FORUM Ophthalmic Data Management System, the new Glaucoma Workplace features FORU…
Issuing First Report On NTDs, WHO Aims For ‘Complete Control’ By 2015
The WHO “said on Thursday that it was aiming for ‘complete control’ by 2015 of tropical diseases that affect one billion impoverished people” and kill an estimated 534,000 people each year, Agence France-Presse reports (10/14)…
Douglas A. Jabs, M.D., Honored With Jackson Memorial Lecture By The American Academy Of Ophthalmology
Douglas A. Jabs, MD, MBA, Professor and Chair of the Department of Ophthalmology, CEO of the Faculty Practice Associates, and Dean for Clinical Affairs at The Mount Sinai Medical Center, has been selected to deliver the prestigious Jackson Memorial Lec…
Do Anti-VEGF Injections Increase the Risk of Stroke or Heart Attack?
By Dr. Ari WeitznerSome have speculated that the anti-VEGF injections we give to macular degeneration patients may get into the bloodstream and have adverse vascular effects. According to a recently released retrospective study (appearing in the October 2010 issue of the Archives of Ophthalmology), using vascular endothelial growth factor (VEGF) blockers to treat neovascular age-related […]
Eye Exercises Might Boost Fine Depth Perception
A new study says a push-pull training method is a good way to correct a condition called sensory eye dominance, in which an imbalance between the vision strength of the eyes impairs fine depth perception.